SUMMIT (dpa-AFX) - Celgene Corp.'s (CELG) unit, Celgene International Sàrl, announced that Tuomo Pätsi has been named President of the company's Europe, Middle East and Africa or EMEA region. He would oversee the present portfolio in EMEA and international efforts related to the firm's broad pipeline of clinical programs in areas like immunotherapy, epigenetics, ubiquitin ligase targets, cancer metabolism and others. Pätsi takes over from Alan Colowick, MD, who has headed Celgene in the region since 2012 and who returns to the U.S., taking on another senior strategic position for the company.
His appointment as President follows over 7 years with the company. Most recently, he served as Corporate Vice President for the South Europe Region; as General Manager, Regional Vice President for the North Europe Region; and as Head of European Marketing.
Copyright RTT News/dpa-AFX